Camber Capital Management’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,400,000
Closed -$56.2M 33
2025
Q1
$56.2M Sell
1,400,000
-58,333
-4% -$2.45M 2% 13
2024
Q4
$66.8M Hold
1,458,333
1.54% 19
2024
Q3
$68.4M Hold
1,458,333
2.17% 16
2024
Q2
$61.6M Buy
1,458,333
+281,944
+24% +$12.4M 1.71% 19
2024
Q1
$52M Buy
1,176,389
+596,410
+103% +$27.2M 1.27% 20
2023
Q4
$26.7M Buy
579,979
+202,757
+54% +$8.62M 0.68% 27
2023
Q3
$16.2M Buy
+377,222
New +$17.6M 0.53% 32
2023
Q1
Sell
-707,292
Closed -$37.4M 43
2022
Q4
$37.4M Buy
+707,292
New +$34.9M 1.28% 22

Other funds holding QGEN

Camber Capital Management's QGEN Position: Q2 2025 in Review

Camber Capital Management sold out of Qiagen (QGEN) in Q2 2025, closing a stake of 1,400,000 shares — an estimated $56.2M sold.

Camber Capital Management first reported a position in QGEN in Q4 2022 and held it in 8 quarters. The position peaked at $68.4M in Q3 2024. 317 funds tracked by Wall St. Rank hold QGEN as of Q2 2025.

  • Camber Capital Management reported no remaining Qiagen position as of Q2 2025 after selling out during the quarter.
  • Camber Capital Management sold 1,400,000 Qiagen shares in Q2 2025, an estimated $56.2M.
  • Camber Capital Management first reported a position in Qiagen in Q4 2022 and held it in 8 quarters.
  • Camber Capital Management's Qiagen position peaked at $68.4M in Q3 2024.
  • 317 funds tracked by Wall St. Rank held Qiagen as of Q2 2025.

Based on Camber Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.